ATE247973T1 - Verfahren zur kontrolle von antibiotikaresistenten grampositiven bakterien und behandlung von infektionen - Google Patents

Verfahren zur kontrolle von antibiotikaresistenten grampositiven bakterien und behandlung von infektionen

Info

Publication number: ATE247973T1
Authority: AT; Austria
Prior art keywords: resistant; gramp; positive bacteria; treating infections; antibiotic
Prior art date: 1995-06-23

Application number

AT96921757T

Other languages

English (en)

Inventor

Peter Blackburn

Beth P Goldstein

Original Assignee

Ambi Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-23

Filing date

1996-06-21

Publication date

2003-09-15

1996-06-21 Application filed by Ambi Inc filed Critical Ambi Inc

2003-09-15 Application granted granted Critical

2003-09-15 Publication of ATE247973T1 publication Critical patent/ATE247973T1/de

Links

241000894006 Bacteria Species 0.000 title 1
208000015181 infectious disease Diseases 0.000 title 1
241001465754 Metazoa Species 0.000 abstract 1
NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 abstract 1
108010053775 Nisin Proteins 0.000 abstract 1
244000052616 bacterial pathogen Species 0.000 abstract 1
239000003899 bactericide agent Substances 0.000 abstract 1
230000003115 biocidal effect Effects 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000004309 nisin Substances 0.000 abstract 1
235000010297 nisin Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Saccharide Compounds (AREA)

AT96921757T 1995-06-23 1996-06-21 Verfahren zur kontrolle von antibiotikaresistenten grampositiven bakterien und behandlung von infektionen ATE247973T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US43595P	1995-06-23	1995-06-23
PCT/US1996/010756 WO1997000694A1 (en)	1995-06-23	1996-06-21	A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection

Publications (1)

Publication Number	Publication Date
ATE247973T1 true ATE247973T1 (de)	2003-09-15

Family

ID=21691527

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96921757T ATE247973T1 (de)	1995-06-23	1996-06-21	Verfahren zur kontrolle von antibiotikaresistenten grampositiven bakterien und behandlung von infektionen

Country Status (18)

Country	Link
US (1)	US5866539A (de)
EP (1)	EP0833657B1 (de)
JP (1)	JP4236699B2 (de)
KR (1)	KR19990028283A (de)
CN (1)	CN1138560C (de)
AT (1)	ATE247973T1 (de)
AU (1)	AU713050B2 (de)
BR (1)	BR9609281A (de)
CA (1)	CA2225530C (de)
CZ (1)	CZ290578B6 (de)
DE (1)	DE69629691T2 (de)
ES (1)	ES2201189T3 (de)
IL (2)	IL122248A0 (de)
NO (1)	NO976028D0 (de)
NZ (1)	NZ311535A (de)
RU (1)	RU2202360C2 (de)
SK (1)	SK285563B6 (de)
WO (1)	WO1997000694A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5910479A (en) *	1996-10-18	1999-06-08	Ambi Inc.	Method for the treatment of Streptococcus pneumoniae infection
US5985823A (en) *	1997-06-09	1999-11-16	Ambi Inc.	Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
EP1212006B1 (de) *	1999-08-31	2006-02-22	Gore Enterprise Holdings, Inc.	Verbesserte zahnseide mit niedriger dichte
NL1013861C2 (nl) *	1999-12-15	2001-06-18	Stichting Tech Wetenschapp	Toepassing van Nisine of derivaat daarvan.
US6403652B1 (en)	2000-06-30	2002-06-11	Colgate-Palmolive Company	Method and composition
AP2005003346A0 (en) *	2002-12-10	2005-06-30	Biosynexus Inc	Topical anti-infective formulations
CA2617133C (en) *	2005-07-28	2014-09-30	Biosynexus Incorporated	Compositions and methods for treating bacteria
WO2007044745A1 (en) *	2005-10-11	2007-04-19	Biosynexus Incorporated	Lantibiotic and mupirocin compositions for treating bacterial infections
GB0600928D0 (en)	2006-01-17	2006-02-22	Novacta Biosystems Ltd	Improvements relating to lantibiotics
US20070238652A1 (en) *	2006-02-08	2007-10-11	Biosynexus Incorporated	Neutralization of bacterial spores
ITMI20060678A1 (it) *	2006-04-06	2007-10-07	Sanofi Aventis Otc S P A	Composto peptidico ad attivita' b iologica sua preparazione e sue applicazioni
GB0714030D0 (en) *	2007-07-18	2007-08-29	Novacta Biosystems Ltd	The use of type-B lantibiotic-based compounds having antimicrobial activity
GB0714029D0 (en)	2007-07-18	2007-08-29	Novacta Biosystems Ltd	Lantibiotic-based compounds having antimicrobial activity
RU2381016C1 (ru) *	2008-09-17	2010-02-10	Сергей Васильевич Федотов	Способ профилактики энтерококковой инфекции кур несушек
CA2742753A1 (en) *	2008-11-24	2010-05-27	Sentinella Pharmaceuticals, Inc. ("Sentinella")	Lantibiotic carboxyamide derivatives with enhanced antibacterial activity
KR101107764B1 (ko) *	2009-01-05	2012-01-20	박세준	항 유해균 기능을 가진 에스제이피미생물
ES2520165T3 (es)	2009-01-14	2014-11-11	Novacta Biosystems Limited	Derivados de desoxiactagardina
CN102388060B (zh)	2009-02-04	2014-09-10	诺瓦克塔生物系统有限公司	阿肽加定衍生物
US20100233669A1 (en) *	2009-03-11	2010-09-16	Cryolife, Inc.	Bioburden-reducing antibiotic composition and method of use
GB201001688D0 (en)	2010-02-02	2010-03-17	Novacta Biosystems Ltd	Compounds
RU2430373C1 (ru) *	2010-06-17	2011-09-27	Федеральное государственное учреждение "Федеральный научный центр трансплантологии и искусственных органов имени академика В.И. Шумакова" Министерства здравоохранения и социального развития Российской Федерации	Способ коррекции антибиотикотерапии у пациента кардиохирургического профиля
US8377143B2 (en)	2010-07-06	2013-02-19	Cryolife, Inc.	Tissue implants for implantation and methods for preparing the same
US8475827B2 (en)	2010-07-06	2013-07-02	Cryolife, Inc.	Tissue implants for implantation and methods for preparing the same
GB201013513D0 (en)	2010-08-11	2010-09-22	Novacta Biosystems Ltd	Formulations
US8182842B1 (en)	2010-11-10	2012-05-22	The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration	Physico-chemical-managed killing of penicillin-resistant static and growing gram-positive and gram-negative vegetative bacteria
RU2638814C1 (ru) *	2016-09-27	2017-12-15	Федеральное государственное бюджетное учреждение "Федеральный научный центр трансплантологии и искусственных органов имени академика В.И. Шумакова" Министерства здравоохранения Российской Федерации	Способ профилактики инфекционных осложнений бактериальной природы после операции на сердце, проведенной в условиях искусственного кровообращения
CN108982430B (zh) *	2017-05-31	2020-09-29	北京大学	标记细菌菌群样品的试剂盒、方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4931390A (en) *	1986-04-16	1990-06-05	Public Health Research Institute Of The City Of New York, Inc.	Expression of the cloned lysostaphin gene
US5217950A (en) *	1988-06-22	1993-06-08	Applied Microbiology, Inc.	Nisin compositions for use as enhanced, broad range bactericides
US5260271A (en) *	1988-06-22	1993-11-09	Applied Microbiology, Inc.	Nisin compositions for use as enhanced broad range bactericides
US5334582A (en) *	1988-06-22	1994-08-02	Applied Microbiology, Inc.	Pharmaceutical bacteriocin compositions and methods for using the same
US4980163A (en) *	1989-03-01	1990-12-25	Public Health Research Institute Of The City Of New York	Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection
US5512269A (en) *	1993-06-09	1996-04-30	Burroughs Wellcome, Co.	Method of treating retained pulmonary secretions

1996
- 1996-06-21 DE DE69629691T patent/DE69629691T2/de not_active Expired - Lifetime
- 1996-06-21 AU AU62891/96A patent/AU713050B2/en not_active Ceased
- 1996-06-21 SK SK1726-97A patent/SK285563B6/sk not_active IP Right Cessation
- 1996-06-21 EP EP96921757A patent/EP0833657B1/de not_active Expired - Lifetime
- 1996-06-21 RU RU97121577/14A patent/RU2202360C2/ru not_active IP Right Cessation
- 1996-06-21 IL IL12224896A patent/IL122248A0/xx unknown
- 1996-06-21 JP JP50399597A patent/JP4236699B2/ja not_active Expired - Fee Related
- 1996-06-21 AT AT96921757T patent/ATE247973T1/de not_active IP Right Cessation
- 1996-06-21 CA CA002225530A patent/CA2225530C/en not_active Expired - Fee Related
- 1996-06-21 US US08/667,650 patent/US5866539A/en not_active Expired - Lifetime
- 1996-06-21 KR KR1019970709597A patent/KR19990028283A/ko not_active Ceased
- 1996-06-21 WO PCT/US1996/010756 patent/WO1997000694A1/en not_active Ceased
- 1996-06-21 ES ES96921757T patent/ES2201189T3/es not_active Expired - Lifetime
- 1996-06-21 CN CNB961949406A patent/CN1138560C/zh not_active Expired - Fee Related
- 1996-06-21 BR BR9609281A patent/BR9609281A/pt unknown
- 1996-06-21 NZ NZ311535A patent/NZ311535A/en not_active IP Right Cessation
- 1996-06-21 CZ CZ19974025A patent/CZ290578B6/cs not_active IP Right Cessation
1997
- 1997-11-19 IL IL122248A patent/IL122248A/en not_active IP Right Cessation
- 1997-12-22 NO NO976028A patent/NO976028D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
IL122248A (en)	2009-09-01
KR19990028283A (ko)	1999-04-15
BR9609281A (pt)	1999-06-15
NZ311535A (en)	2001-05-25
NO976028L (no)	1997-12-22
SK285563B6 (sk)	2007-03-01
CZ290578B6 (cs)	2002-08-14
DE69629691T2 (de)	2004-02-26
CZ402597A3 (cs)	1998-09-16
AU713050B2 (en)	1999-11-25
US5866539A (en)	1999-02-02
JPH11508265A (ja)	1999-07-21
SK172697A3 (en)	1998-12-02
NO976028D0 (no)	1997-12-22
IL122248A0 (en)	1998-04-05
CA2225530C (en)	2002-08-20
CN1138560C (zh)	2004-02-18
ES2201189T3 (es)	2004-03-16
EP0833657B1 (de)	2003-08-27
JP4236699B2 (ja)	2009-03-11
EP0833657A1 (de)	1998-04-08
WO1997000694A1 (en)	1997-01-09
AU6289196A (en)	1997-01-22
CA2225530A1 (en)	1997-01-09
RU2202360C2 (ru)	2003-04-20
DE69629691D1 (de)	2003-10-02
CN1188415A (zh)	1998-07-22

Legal Events

Date	Code	Title	Description
2004-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE247973T1 (de)	2003-09-15	Verfahren zur kontrolle von antibiotikaresistenten grampositiven bakterien und behandlung von infektionen
NO982311L (no)	1998-07-22	Sammensetninger og fremgangsmÕter for forhindring og behandling av oral muscositt
DE69834339D1 (de)	2006-06-01	Verwendung einer zusammensetzung die einen chelatbildner und eine antimikrobielle verbindung enthaltet zur behandlung von biofilmen
ATE448791T1 (de)	2009-12-15	Methoden und zusammensetzungen für die behandlung von glomerulonephritis
CY1108437T1 (el)	2014-04-09	Φαρμακοτεχνικες μορφες οι οποιες περιεχουν μια ενωση κεφαλοσπορινης και η χρηση τους στη θεραπεια βακτηριακων λοιμωξεων σε γατους και σκυλους
BR9507099A (pt)	1997-09-16	Forma de dosagem método de esterilização composição esterilizante e suplemento alimentar animal compreendendo nitrito acidificado como um agente anti-microbiano
ATE231686T1 (de)	2003-02-15	Schädlingsbekämpfungsmittel zur behandlung von saatgut
DE69835536D1 (de)	2006-09-21	Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
ATE180944T1 (de)	1999-06-15	Tuberkilizide synergistische desinfizierende zusammensetzung und verfahren zur desinfektion
DE69928384D1 (de)	2005-12-22	Behandlung und nachweis von staphylokokkeninfektionen
DE69631381T2 (de)	2004-10-21	Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
DE69415515D1 (de)	1999-02-04	Orale präparate zur behandlung von plaque und gingivitis, die einen nicht-kationischen antibakteriellen wirkstoff und ein bikarbonatsalz enthalten
ATE359816T1 (de)	2007-05-15	Verfahren zur prävention und behandlung von infektionen mit dem flavivirus bei tieren
DE69305886D1 (de)	1996-12-19	Verfahren zur bakteriellen Behandlung von mit Flora verschmutzten Kreisläufen der Papierindustrie
DE60114778D1 (de)	2005-12-15	Behandlung von infektionen in tieren
EP1011664A4 (de)	2001-05-16	8a-AZALIDEN ALS ANTIMIKROBIELLE AGENTEN
DE69716056D1 (de)	2002-11-07	Acylurea-verbindungen zur behandlung von coccidioidomycosis bei warmblütigen tieren
DE69906701D1 (de)	2003-05-15	Topische verwendung von loperamid zur behandlung mikrobieller infektionen
DE69034147D1 (de)	2004-07-22	Verfahren zur Desinfektion von Knochengeweben
DE60222298D1 (de)	2007-10-18	Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem beta-lactam-antibiotikum
HUP0000146A2 (hu)	2000-06-28	Eljárás Streptococcus pneumoniae-fertőzés kezelésére
HUP9901183A2 (hu)	1999-07-28	Készítmények és eljárások az orális mukozitisz megakadályozására és kezelésére
ATA18095A (de)	1997-03-15	Verfahren zur desinfektion von pflanzengut bzw. pflanzengewebsgut
DE60228324D1 (de)	2008-09-25	Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem antibakteriellen carbapenem-mittel
DE69906729D1 (de)	2003-05-15	Zusammensetzung und methode zur behandlung von pseudomonas aeruginosa infektionen